Earnings Look Back: NYSE Euronext Is Up 6.5% Since Reporting Q...

- ATS Brasil to Seek Stock Exchange License 13 May - NYSE Keeps Options Open to Exit Euronext 10 May - Court Won't Block Vote on NYSE and ICE Deal By Chris Dieterich NEW YORK--A sharp drop that drove Anadarko Petroleum Corp.'s (APC) to a penny in ...

(Financial News Network On) One of today's notable stocks on the rise is NYSE Euronext (NYSE:NYX), up 1.7% to $41.38. The Dow is up 0.4% to 15,292 and the S&P is currently up 0.5% to 1,658. NYSE Euronext (NYSE:NYX) is currently priced 5.0% above ...

By Alicia Suminsky Bell Ceremony to celebrate the partnership between Junior Achievement Europe and NYSE Euronext On 26 April 2013, Caroline Jenner, CEO of JA-YE Europe opened the European stock markets with a Bell Ceremony at NYSE Euronext ...

April 19, New York: Celebrating NYSE Euronext partner nonprofits delivering financial literacy tools to children The final Financial Capability Week event at the NYSE in the US was a bell celebrating partner nonprofits helping to improve the ...

By Renate Mantjes April 12, Amsterdam: Financial Markets and the Role of the Exchange Students visit NYSE Euronext Amsterdam in honor of Financial Capability Week Students of the Atheneum College Hageveld visited the historic Beursplein 5 ...

Jean Mizrahi, CEO Ymagis, closes the trading day in Paris. Ymagis supplies digital services and technologies for the film industry. The group provides projection equipment migration and film digitizing services to producers, distributors of films ...

StreetInsider.com - Form 4 NYSE Euronext For: May 09 Filed by: GELTZEILER

Barclays downgraded NYSE Euronext (NYSE: NYX) from Overweight to Equalweight with a price target of $42.00 (from $40.00). For an analyst ratings summary and ratings history on NYSE Euronext click here. For more ratings news on NYSE Euronext click ...

Biotech company Pharming Group NV (NYSE:PHARM) (Euronext: PHARM) reported today a net loss of EUR5.4m for the first quarter of 2013, ended 31 March 2013. This was an improvement over the net loss of EUR6.5m in Q1 2012. Revenues and other income for ...